Elon Musk has revealed he has upgraded from Ozempic to Mounjaro, nicknamed the “King Kong” of weight-loss drugs, in a photo ...

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

The growing popularity of GLP-1 receptor agonists—including Ozempic and Wegovy from Novo Nordisk, and Mounjaro and Zepbound ...

A Yardley pharmaceutical company will implement a 1-for-15 reverse stock split in an effort to increase its share price and ...

The Tesla CEO told X users he is currently taking Mounjaro because it "seems to have fewer side effects and be more effective ...

In a social media post shared on Christmas Day, billionaire Elon Musk revealed that he has been using the prescription drug ...

In a new study, researchers examined the health effects people experienced when they returned to still-standing homes after ...

Elon Musk admits that he uses an infamous weight loss drug akin to Ozempic in a Christmas post while posing in a Santa Claus ...

MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.

The drug slows digestion, reduces hunger, and promotes a feeling of fullness, helping people consume fewer calories. This ...

He also revealed in a separate post he is taking the weight-loss drug Mounjaro. (X/@elonmusk) The mega-billionaire, who Trump ...